A Phase 3, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of DRM04 in Subjects With Axillary Hyperhidrosis
Phase of Trial: Phase III
Latest Information Update: 17 Feb 2018
At a glance
- Drugs Glycopyrrolate (Primary)
- Indications Hyperhidrosis
- Focus Registrational; Therapeutic Use
- Acronyms ATMOS-2
- Sponsors Dermira
- 17 Feb 2018 According to the Dermira media release, from two phase III (ATMOS-1 & ATMOS-2) studies were presented during the Late-Breaking Research Forums at the 76th Annual Meeting of the American Academy of Dermatology (AAD).
- 17 Feb 2018 Results from ATMOS-1 and ATMOS-2 trials published in a Dermira media release.
- 12 Feb 2018 According to Dermira media release, data from two phase III (ATMOS-1 & ATMOS-2) studies will be presented at the 76th Annual Meeting of the American Academy of Dermatology (AAD).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History